Topic Archives: Ultragenyx (RARE)

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]

Comments

  • Avatar

    $RARE Ultragenyx (RARE) shares drop as muscle-disease drug study fails (8/22) Ultragenyx Pharmaceutical Inc. RARE,...

  • Avatar

    Ultragenyx ($RARE) mentioned by Citigroup as one of six next takeover targets in the next 12-18 months after Relypsa and...

  • DrKSSMDPhD

    Ultragenyx $RARE has presented positive clinical data from a late stage trial of mucopolysaccharidosis type 7, among man...

  • DrKSSMDPhD

    Ultragenyx $RARE started at overweight by Piper Jaffray, with PT $70. Long $RARE. Strong M&A candidate. HN score ...

  • DrKSSMDPhD

    Takeda investing in and partnering with Ultragenyx $RARE. Among my favorite holdings. HN score A. I have big paper profi...

  • DrKSSMDPhD

    Despite 100 percent run up this year, Stifel Nicolaus (finger on the pulse!) initiates UltraGenyx $RARE as buy with $125...

  • DrKSSMDPhD

    JMP initiates coverage of Ultragenyx $RARE this am with, buy recommendation and $119 PT. Long $RARE....great ultra-o...

  • DrKSSMDPhD

    Biotech set for strong open. Love the news out of Ultragenyx $RARE. Shaping up to be my fastest 100 percent gainer of al...

  • DrKSSMDPhD

    I cannot share the market's enthusiasm for BioMarin $BMRN and its dwarfism remedy. There is no evidence whatsoever that ...

  • DrKSSMDPhD

    Ultragenyx (RARE) should be on the move up today. Very nice positive phase 2 interim data with x-linked hypophosphat...

  • DrKSSMDPhD

    A reminder that I have been long in Ultragenyx ($RARE) since the beginning of the year. This stock is up 33 percent for...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info